Skip to main content

Table 2 Summary of published cases of blood stream infection due to Pandoraea species

From: Clinical and microbiological features of obstructive cholangitis with bloodstream infection caused by Pandoraea apista identified by MALDI-TOF mass spectrometry and ribosomal RNA sequencing in a cancer patient

Author, country, year, reference

Age (years), sex

Strains

Symptoms

Underlying condition

Diagnostic method

Susceptibility MIC (μg/mL)

Other bacteria isolated

Treatment for Pandoraea

Outcome

Stryjewski et al., 2003 (USA) [12]

30, M

P. pnomenusa

Fever, hypotension

Pneumonia, pulmonary sarcoidosis, lung transplantation

PCR, gyrB gene sequencing

Zone diameter: IPM 33 mm; MEPM 6 mm

None

IPM, until dead

Died

Johnson et al., 2004 (USA) [13]

16, M

P. apista

Fever

CLABSI,

cystic fibrosis

16S rRNA sequencing

ND

Candida albicans

CVC removal,

IPM and CTRX, 14 days

Survived

Falces-Romero et al., 2016 (Spain) [14]

10 months, F

P. pnomenusa

Fever, shaking chill

CLABSI, Leukemia

MALDI-TOF MS

Susceptible for MINO and IPM (Details unknown)

None

CVC removal,

IPM, 10 days

Survived

Xiao et al., 2019 (China) [15]

43, M

P. sputorum

Elevated inflammatory markers

Hepatocellular carcinoma, liver transplantation

MALDI-TOF MS, 16S rRNA sequencing

AMK 32; AZT > 64; CFPM > 64; CAZ > 64; CPFX ≤ 0.5; CTRX ≤ 0.5; GM > 16; IPM ≤ 0.5; LVFX ≤ 1; MEPM 16; MINO ≤ 1; PIPC ≤ 16; PIPC/TAZ ≤ 8/4; ST ≤ 38/2

None

IPM and CTRX/TAZ

Survived

Gawalkar et al., 2020 (India) [16]

42, M

P. pnomenusa

Fever, dyspnea

IE, prosthetic aortic valve replacement

ND

Susceptible for LVFX, MINO, ST (Details unknown)

none

LVFX

Died

Bodendoerfer et al., 2021 (Switzerland) [17]

37, M

P. pnomenusa

Fever

CLABSI, prosthetic valve endocarditis, IDU

Whole-genome sequencing

Strain 1: CAZ 24; CPFX 0.5; IPM 1.5; MEPM ≥ 32; MINO 0.38; PIPC 24; PIPC/TAZ 0.19; ST 0.64

none

CVC removal, PIPC/TAZ, ST

Survived

Strain 2: CAZ 16; CPFX 0.5; IPM 1.5; MEPM ≥ 32; PIPC 8; PIPC/TAZ 0.047; ST 0.64

Singh et al., 2021 (India) [6]

72, M

P. apista

Fever, dyspnea, gastric upset, diarrhea

COVID-19

MALDI-TOF MS

Susceptible for IPM, MINO, DOXY and ST; Resistant for CAZ, MEPM, PIPC/TAZ, colistin, AMK, CPZ/SBT (Details unknown)

none

IPM

Survived

Present case

61, M

P. apista

Fever

Colorectal cancer, renal cell carcinoma, DM

MALDI-TOF MS, 16S rRNA sequencing

See Table 1

none

ST

Survived

  1. M male, F female, MIC minimum inhibitory concentration, CLABSI central line-associated bloodstream infection, CVC central venous catheter, PCR polymerase chain reaction, rRNA ribosomal RNA, MALDI-TOF MS matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry, AMK amikacin, AZT aztreonam, CFPM cefepime, CAZ ceftazidime, CPFX ciprofloxacin, CTRX ceftriaxone, GM gentamycin, IPM imipenem, LVFX levofloxacin, MEPM meropenem, MINO minocycline, PIPC piperacillin, PIPC/TAZ piperacillin/tazobactam, ST sulfamethoxazole trimethoprim, IDU injecting drug user, DOXY doxycycline, CPZ/SBT cefoperazone-sulbactam, COVID-19 coronavirus disease 2019, DM diabetes, ND no data, IE infective endocarditis